Simbionix U.S.A. Corp., the world's leading provider of medical education and simulation training products for medical professionals and the healthcare industry, is pleased to announce that William Lewandowski has been promoted to the position of VP for US Business Development.
Lewandowski has more than 21 years of experience in the design, development, implementation, and evaluation of simulation in healthcare, aviation, and defense, including having served as the company's U,S, Director of Marketing for the past few years. He has published and presented in a number of international peer-reviewed venues on both simulation and instructional design and has served in an advisory capacity on these subjects to various US and international clinical boards and societies. He holds a Masters of Science degree in instructional and performance technology from Boise State University and is pursuing a PhD in health sciences at the University of Liverpool.
"Bill embodies the core principle of Simbionix, that a world-class medical device combined with world-class simulation and curriculum results in a superior clinician who can deliver improved patient outcomes," says Gary Zamler, CEO of Simbionix. "Bill's unique combination of experience within the medical simulation industry, and education makes him the ideal person to not only expand our industry business, but also to work with our industry partners to ensure that we are part of the solution for improving the quality of healthcare in North America."
Latest from Today's Medical Developments
- NextDent 300 MultiJet printer delivers a “Coming of Age for Digital Dentistry” at Evolution Dental Solutions
- Get recognized for bringing manufacturing back to North America
- Adaptive Coolant Flow improves energy efficiency
- VOLTAS opens coworking space for medical device manufacturers
- MEMS accelerometer for medical implants, wearables
- The compact, complex capabilities of photochemical etching
- Moticont introduces compact, linear voice coil motor
- Manufacturing technology orders reach record high in December 2025